LPL Financial’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $749K | Buy |
231,115
+161,312
| +231% | +$471K | ﹤0.01% | 4670 |
|
|
2026
Q1 | $172K | Buy |
69,803
+4,947
| +8% | +$10.5K | ﹤0.01% | 5548 |
|
|
2025
Q4 | $133K | Buy |
64,856
+23,443
| +57% | +$67.7K | ﹤0.01% | 5545 |
|
|
2025
Q3 | $144K | Sell |
41,413
-2,517
| -6% | -$7.03K | ﹤0.01% | 5433 |
|
|
2025
Q2 | $96.6K | Sell |
43,930
-2,556
| -5% | -$4.18K | ﹤0.01% | 5273 |
|
|
2025
Q1 | $53.9K | Sell |
46,486
-6,842
| -13% | -$10.1K | ﹤0.01% | 5147 |
|
|
2024
Q4 | $67.7K | Sell |
53,328
-12,293
| -19% | -$31.3K | ﹤0.01% | 5071 |
|
|
2024
Q3 | $224K | Sell |
65,621
-12,699
| -16% | -$55.3K | ﹤0.01% | 4650 |
|
|
2024
Q2 | $366K | Buy |
78,320
+6,844
| +10% | +$38.6K | ﹤0.01% | 4110 |
|
|
2024
Q1 | $530K | Sell |
71,476
-5,202
| -7% | -$43.2K | ﹤0.01% | 3732 |
|
|
2023
Q4 | $777K | Sell |
76,678
-2,794
| -4% | -$24.5K | ﹤0.01% | 3278 |
|
|
2023
Q3 | $620K | Buy |
79,472
+2,915
| +4% | +$25K | ﹤0.01% | 3299 |
|
|
2023
Q2 | $630K | Buy |
76,557
+14,086
| +23% | +$123K | ﹤0.01% | 3236 |
|
|
2023
Q1 | $453K | Buy |
62,471
+13,420
| +27% | +$119K | ﹤0.01% | 3416 |
|
|
2022
Q4 | $435K | Buy |
49,051
+5,335
| +12% | +$58.6K | ﹤0.01% | 3381 |
|
|
2022
Q3 | $535K | Sell |
43,716
-1,044
| -2% | -$16.3K | ﹤0.01% | 3090 |
|
|
2022
Q2 | $530K | Buy |
44,760
+6,831
| +18% | +$91.5K | ﹤0.01% | 3146 |
|
|
2022
Q1 | $721K | Sell |
37,929
-5,643
| -13% | -$105K | ﹤0.01% | 2888 |
|
|
2021
Q4 | $1.16M | Sell |
43,572
-9,056
| -17% | -$312K | ﹤0.01% | 2535 |
|
|
2021
Q3 | $2.16M | Buy |
52,628
+3,794
| +8% | +$208K | ﹤0.01% | 1982 |
|
|
2021
Q2 | $2.77M | Sell |
48,834
-16,081
| -25% | -$594K | ﹤0.01% | 1735 |
|
|
2021
Q1 | $2.73M | Buy |
64,915
+5,205
| +9% | +$297K | ﹤0.01% | 1626 |
|
|
2020
Q4 | $4.19M | Buy |
59,710
+2,304
| +4% | +$94.6K | 0.01% | 1215 |
|
|
2020
Q3 | $1.61M | Buy |
57,406
+4,844
| +9% | +$158K | ﹤0.01% | 1583 |
|
|
2020
Q2 | $1.55M | Buy |
52,562
+27,798
| +112% | +$726K | ﹤0.01% | 1517 |
|
|
2020
Q1 | $491K | Buy |
24,764
+2,794
| +13% | +$70.5K | ﹤0.01% | 2118 |
|
|
2019
Q4 | $651K | Buy |
21,970
+5,836
| +36% | +$146K | ﹤0.01% | 2146 |
|
|
2019
Q3 | $367K | Sell |
16,134
-4,546
| -22% | -$113K | ﹤0.01% | 2516 |
|
|
2019
Q2 | $512K | Buy |
20,680
+5,283
| +34% | +$126K | ﹤0.01% | 2266 |
|
|
2019
Q1 | $376K | Buy |
15,397
+6,240
| +68% | +$141K | ﹤0.01% | 2452 |
|
|
2018
Q4 | $208K | Sell |
9,157
-3,859
| -30% | -$105K | ﹤0.01% | 2782 |
|
|
2018
Q3 | $414K | Buy |
13,016
+2,520
| +24% | +$81.4K | ﹤0.01% | 2395 |
|
|
2018
Q2 | $376K | Buy |
10,496
+2,786
| +36% | +$98.6K | ﹤0.01% | 2438 |
|
|
2018
Q1 | $256K | Buy |
+7,710
| New | +$275K | ﹤0.01% | 2765 |
|
Other funds holding EDIT
GCP
EAM
LPL Financial's EDIT Position: Q2 2026 in Review
LPL Financial increased its Editas Medicine (EDIT) stake by 231% in Q2 2026, buying an estimated $471K and bringing the position to 231,115 shares worth $749K. The position accounts for ﹤0.01% of the portfolio, ranked #4670.
LPL Financial first reported a position in EDIT in Q1 2018 and has held it in 34 quarters since. The position peaked at $4.19M in Q4 2020. 79 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- LPL Financial held 231,115 shares of Editas Medicine worth $749K as of Q2 2026.
- LPL Financial bought 161,312 Editas Medicine shares in Q2 2026, an estimated $471K.
- Editas Medicine made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4670 holding.
- LPL Financial first reported a position in Editas Medicine in Q1 2018 and has held it in 34 quarters since.
- LPL Financial's Editas Medicine position peaked at $4.19M in Q4 2020.
- 79 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.